TP53-Mutant Clonal Hematopoiesis Marks a High-Risk CAR-T Subgroup
A single-center study of 104 recipients of commercial CD19- or BCMA-directed CAR-T found that overall clonal hematopoiesis (CHIP) was not associated with toxicity, progression-free survival or overall survival. The signal emerged only after genotype…
